AzTrials
AzTrials

HIVNCT06894199

Work2Prevent Plus: Structural Intervention to Promote HIV Care in Black Sexual Minority Men

An observational study of HIV, run by University of Chicago at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to learn about the pilot test of the employment program among young men living with HIV or part of a community highly impacted by HIV. The main question it aims to answer is: What is the feasibility and acceptability of the employment program? Young male participants will attend… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
HIV
What is being tested?
The Work Shop
How many people
132 participants
Where
1 siteUnited States
Study dates
22 Apr 2025to 22 Apr 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Young male cohort will be selected from primary care clinics serving young males; local gathering places and events for young sexual minority males, such as night clubs, House \& Ball events, and other public places that serve the LGBTQ community (e.g., LGBTQ centers).

Who may be able to join

  • Identifying as male
  • Being ages 18-29 years old; AND
  • EITHER living with HIV currently OR identifying with a population highly impacted by HIV (based on race/ethnicity or having ever had sex with another man) OR
  • Being ages 18 or older
  • Participated in facilitation or administrative support for the program, "The Work Shop," at a partnering community-based organization

Who cannot join

  • Participated in the preceding employment intervention, "Work2Prevent"

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • University of Chicago

    Chicago, Illinois, 60637

    Jordan Victorian, 773-702-5915, jordan.victorian@bsd.uchicago.edu

    Darnell Motley, 773-834-5910, dmotley22@bsd.uchicago.edu

    Recruiting

Other trials in United States

About this study

The goal of this observational study is to learn about the pilot test of the employment program among young men living with HIV or part of a community highly impacted by HIV.

The main question it aims to answer is: What is the feasibility and acceptability of the employment program?

Young male participants will attend the two day employment program and will complete four study surveys over the course of 6 months.

Employment program facilitators will complete a study survey and participate in a focus group over the course of 1 day.

Read the detailed description

For this trial, we will recruit, screen, and enroll a sample of 120 young men from our networks of community-based organizations and LGBT-serving partners. Eligible participants will be pre-screened for enrollment by a University of Chicago study research staff/project manager. Next, the research staff will explain the scope of employment program and expectations of enrollees. Those interested in enrolling in the employment program and study will then be invited to an initial session of the employment program.

The overall employment program will consist of 2 days of workshop content focused on employment skills and the relationship between work and health.

Day One. Upon arrival, the program implementers and researchers will explain the employment program and purpose of the research study. University of Chiago research staff will complete informed consent procedures with participants prior to beginning the study baseline questionnaire and ensure that all participants are capable of consenting to participate. Participants will be asked to complete a release of information to access electronic medical records for the purposes of collecting measures of viral load and clinical care visit attendance at each time point.

Baseline (T1). Prior to the start of the first session, participants will be given an iPad tablet and headphones containing a 30-35 minute audio-computer assisted self-interview (ACASI) survey. Self-assessment measures, including: sociodemographic characteristics: age, race/ethnicity, income, incarceration history, and employment history; employment and housing: job seeking self-efficacy, average hours worked in a week (last 30 days), work motivation, job-seeking behavior, and homelessness (last 3 months); and clinical care: receipt of ART/PrEP prescription (past 4 months), visits for HIV/PrEP care (past 6 months), HIV/STI testing visits (past 6 months).

Day Two. Immediate-post program (T2). At the completion of the employment program on the second day, participants will complete a 25-30 minute ACASI survey assessing the feasibility, acceptability, and satisfaction with the employment program.

3-months (T3) and 6-months (T4) post-program. Participants will be contacted by study research staff to complete additional follow-up surveys via private phone conversation or independent completion online through the REDCap data collection platform. Follow-up surveys at 3 months and 6 months post-program will assess all variables addressed at T1.

Conditions
HIV
Being tested
The Work Shop

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The Work ShopOther

    Employment intervention consists of 2 days (about 5 hours each) of interactive educational content focused on a variety of topics.

Study groups in NCT06894199
Study groupRoleWhat they receive
Young Black sexual maleParticipate in two day employment program
Receives: Other: The Work Shop
Employment program facilitatorsLead or support the two day employment program
Receives: Other: The Work Shop

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability of intervention

    Average score among participants of the Information Systems Success Model. The 16-item scale measures information quality, perceived usefulness, and overall satisfaction. Every item is scored on a 1-7 scale, with 1 being "Strongly Disagree" and 7 being "Strongly Agree". Responses are averaged to produce an overall ISSM score (1-7; higher scores indicate higher acceptability/satisfaction).

    Measured: Post-Intervention, week 2

  2. Satisfaction with intervention

    Average score among participants of the Information Systems Success Model. The 16-item scale measures information quality, perceived usefulness, and overall satisfaction. Every item is scored on a 1-7 scale, with 1 being "Strongly Disagree" and 7 being "Strongly Agree". Responses are averaged to produce an overall ISSM score (1-7; higher scores indicate higher acceptability/satisfaction).

    Measured: Post-Intervention, week 2

  3. Workshop feasibility

    Number of participants that complete at least two workshops

    Measured: Immediately after the intervention

  4. Missed sexual healthcare visits

    Ratio of scheduled sexual healthcare visits to missed sexual healthcare visits in the past 6 months

    Measured: Baseline, 3 months and 6 months

  5. Change in participants perceived ability and confident to perform job seeking activities

    Average change in score between baseline and 6 months on Job-Seeking Self-Efficacy scale on participants perceived ability and confidence to perform job seeking activities. The 12-item Job Seeking Self-Efficacy scale uses response values on a 1-10 score, with 1 being "Not at All Confident" and 10 being "Very Confident". Responses are averaged to yield a total score, with higher scores indicating higher self-efficacy. Change in JSS will be calculated by subtracting the JSS score at baseline (T1) from the JSS score at the 3- (T3) and 6-month follow-ups (T4) (-9 to +9; negative change indicates decreased self-efficacy, while positive change indicates increased self-efficacy).

    Measured: Baseline through 6 months

Secondary outcomes (2)
  1. Change in hours worked per week

    Average change in number of reported hours worked each week between baseline and 6 months

    Measured: Baseline through 6 months

  2. Change in self-reported sexual risk behaviors

    Average change in self-reported sexual risk behaviors from baseline through 6 months. Sexual risk behaviors will be measured using 7 (8 for trans male participants) yes/no items assessing for engagement in the following behaviors during the past 6 months:

    1. Condomless anal intercourse (insertive)
    2. Condomless vaginal intercourse (insertive)
    3. Condomless anal intercourse (receptive)
    4. Condomless vaginal intercourse (receptive) - trans men only
    5. Intercourse while under the influence of alcohol
    6. Intercourse while under the influence of marijuana
    7. Intercourse while under the influence of stimulants
    8. Intercourse while under the influence of opioids Responses will be averaged at each assessment. Change in sexual risk behaviors will be calculated by subtracting the baseline value from follow-up (T3 and T4, respectively) values (range: -1 to +1; negative change indicates fewer sexual risk behaviors, while positive change indicates more sexual risk behaviors).

    Measured: Baseline through 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Mar 2025
  2. Study start22 Apr 2025
  3. Primary completion30 Oct 2026 (estimated)
  4. Study completion22 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
132 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06894199
Sponsor's protocol ID
IRB22-0783
Other IDs
K08MH130253
Status last verified
Sep 2026
First submitted
3 Mar 2025
Last updated
30 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: A dataset that has been deidentified will be uploaded to a research data repository at the end of the study. All collected IPD from participants in the trial will be included.

Questions about this trial

What is this clinical trial studying?

An observational study of HIV, run by University of Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jordan Victorian (773-702-5915, jordan.victorian@bsd.uchicago.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability of intervention (time frame: Post-Intervention, week 2). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in